Publications

PO-483 Improved sensitivity for non-invasive diagnosis of high-grade serous ovarian cancer

Authors: E Moore, D Chandrananda, A Piskorz, F Mouliere, T Goranova, H Addley, R Cra...

Research group: Brenton Group,

E-pub date: 1 Jun 2018

Journal name: ESMO Open

Detection of early neoplasia in Barrett’s esophagus using lectin-based near-infrared imaging: an ex vivo study on human tissue.

Authors: AA Neves, M Di Pietro, M O'Donovan, DJ Waterhouse, SE Bohndiek, KM Brindle,...

Research group: , Bohndiek Group

E-pub date: 1 Jun 2018

Journal name: Endoscopy

Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment.

Authors: ME Mayerhoefer, M Raderer, U Jaeger, P Staber, B Kiesewetter, D Senn, FA Ga...

Research group:

E-pub date: 1 Jun 2018

Journal name: Eur J Nucl Med Mol Imaging

6 Imaging tumour metabolism to guide treatment of breast cancer with drugs targeted at PI3K alpha

Authors: S Ros, P D’Santos, D Hu, AJ Wright, RL Hesketh, AS Batra, E Mannion, A Br...

Research group:

E-pub date: 1 Jun 2018

Journal name: ESMO Open

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.

Authors: DWY Tsui, M Murtaza, ASC Wong, OM Rueda, CG Smith, D Chandrananda, RA Soo, ...

Research group:

E-pub date: 1 Jun 2018

Journal name: EMBO Mol Med

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

Authors: SM Waszak, PA Northcott, I Buchhalter, GW Robinson, C Sutter, S Groebner, K...

Research group: Gilbertson Group

E-pub date: 1 Jun 2018

Journal name: Lancet Oncol

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

Authors: GW Robinson, VA Rudneva, I Buchhalter, CA Billups, SM Waszak, KS Smith, DC ...

Research group: Gilbertson Group

E-pub date: 1 Jun 2018

Journal name: Lancet Oncol

THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (IMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

Authors: GW Robinson, VA Rudneva, I Buchhalter, CA Billups, SM Waszak, K Smith, DC B...

Research group: Gilbertson Group

E-pub date: 1 Jun 2018

Journal name: NEURO-ONCOLOGY

Filters

Research Groups

Core Facilities

Start date

End date

PO-483 Improved sensitivity for non-invasive diagnosis of high-grade serous ovarian cancer

Detection of early neoplasia in Barrett’s esophagus using lectin-based near-infrared imaging: an ex vivo study on human tissue.

Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment.

6 Imaging tumour metabolism to guide treatment of breast cancer with drugs targeted at PI3K alpha

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (IMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

Themes

Filters

Research Groups

Core Facilities

Start date

End date

PO-483 Improved sensitivity for non-invasive diagnosis of high-grade serous ovarian cancer

Detection of early neoplasia in Barrett’s esophagus using lectin-based near-infrared imaging: an ex vivo study on human tissue.

Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment.

6 Imaging tumour metabolism to guide treatment of breast cancer with drugs targeted at PI3K alpha

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (IMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)